Unbalanced translocation der (11) 
Introduction
Myelodysplastic syndrome (MDS) is a clonal hematopoietic stem cell disorder characterized by ineffective hematopoiesis that leads to bone marrow failure and/or leukemic transformation. Clonal cytogenetic aberrations are found in 30 to 50% of de nove MDS and 80% of secondary MDS [1, 2] .
In contrast to acute myeloblastic leukemia (AML) having preferentially balanced translocations, total or partial chromosome losses and chromosome gains are predominantly observed and balanced translocations are rare in MDS [1] [2] [3] . Although several chromosomal changes including 5q-, -7, and +8 are strongly associated with MDS, neither aberration is specific to MDS [2, 4] .
Unbalanced translocations, which are created if one of the two derivative chromosomes is lost, are frequently found in MDS [2] . They are usually detected as a part of complex karyotypes, diagnostically nonspecific and related to disease progression [5] . Some recurrent unbalanced translocations, such as der(17)t(5;17)(p11;p11) leading to 17p deletion and der(16)t(1;16)(q11;q11) resulting in 1q trisomy, have been reported and characterized in MDS [2, 3] .
On the other hand, chromosomal translocations involving 11q23 have been observed in a variety of hematological malignancies including acute lymphoblastic leukemia (ALL), AML and MDS [6] . The majority of these translocations result in the rearrangement of the MLL gene, although the incidence of MLL rearrangements in MDS has not been defined [3] . In addition, most typical 11q23 translocations, such as t(4;11), t(9;11) and t (11;19) , are not found in MDS. Therefore, the pathological roles of 11q23 rearrangements in MDS remain to be completely elucidated.
We describe here two cases of MDS with an unbalanced translocation der(11)t(11;12)(q23;q13) involving 11q23 as a part of complex karyotypes.
The results indicate that the der(11)t(11;12)(q23;q13) is one of the non-random aberrations and may be implicated in the pathogenesis of advanced-stage MDS. 
Materials and methods

Chromosome analysis and Spectral Karyotyping (SKY)
Chromosome analyses were performed on short-term culture of the cells obtained from bone marrow by the G-banding technique. Karyotypes were described according to the International System for Human Cytogenetic Nomenclature (ISCN 1995) [7] . Spectral karyotyping (SKY) was carried out with SkyPaint TM kit (Applied Spectral Imaging, Migdal Ha'Emek, Israel) according to the manufacturer's instructions. A total of 5 metaphase spreads were analyzed for spectral karyotyping.
Fluorescence in situ hybridization (FISH) analysis
Probes 
Results
Case 1
Chromosome analysis at the initial diagnosis showed the complex karyotypes as follows:
43,XX,-1,add(2)(q35),-3,-5,-7,der (11) [7] .
To identify the origin of additional chromosomes and marker chromosomes, we applied SKY analysis on metaphase spreads of the same sample preparation obtained at the relapse. SKY analysis revealed that marker chromosomes were derived from several unbalanced translocations. Therefore, the karyotype at the relapse was revised as follows ( Fig. 2A) :
42,XX,der(1)del(1)(p?)t(1;3)(q21;?),der(2)t(2;5)(q35;?),-3,del(5)(q?),der (7) t(5;7)(?;?),der(11)t(1;11)(q11;p15)t(11;12)(q23;q13),-12,-16,der (18) To confirm some of the SKY findings, we performed FISH analyses with CSF1R (5q33-34) and D7S486, D7S522 (7q31) as a probe on interphase nuclei because chromosome abnormalities of 5q and 7q are important in the pathogenesis of MDS. The regions of 5q33-34 and 7q31 were deleted although the region of 5p15 and the centromere of chromosome 7
were preserved (Fig. 3A, 3B ). The results indicated that aberrations of chromosomes 5 and 7 were derived from unbalanced translocations or par-tial deletions, but not total losses of chromosomes 5 and 7 shown by G-banding.
G-banding and SKY analyses identified t(11;12)(q23;q13) and t(1;11)(q11;p15) translocations, suggesting that the MLL gene at 11q23 and the NUP98 gene at 11p15 may be involved in these translocations. Hence, we performed FISH analyses with MLL and NUP98 probes on metaphase spreads and interphase nuclei at the relapse. However, the MLL signals were located on the der(11) and normal chromosome 11 (Fig.4A) . The NUP98 signals were also not split and located on the der(11) and normal chromosome 11 ( Fig.5 and data not shown). The results indicated that the breakpoints at 11q23 and 11p15 on the der(11) were telomeric to the MLL gene and the NUP98 gene, respectively.
Case 2
Cytogenetic analysis showed complex karyotypes as follows (Fig. 1B) 41,X,-Y,der(3)(3qter->3q21::3p25->3qter),der(5)t(5;10)(q11;?),der(7)del (7) (p?)del(7)(q?),der(7)t(7;20)(p13;?)t(7;18)(q11;q11),der(11)t(11;12)(q23; q13),-12,der(13)t(13;17)(q11;q11),-14,der(16)t(14;16)(q13;q12),-17,-18, -20.
FISH analyses with CSF1R and D7S486, D7S522 probes were carried out and showed that the regions of 5q33-34 and 7q31 were deleted although the 5p15 region and centromere of chromosome 7 remained as observed in case 1 (data not shown).
For further characterization of der(11)t(11;12)(q23;q13), we performed FISH analysis with MLL probe. The MLL signals were also remained on the der(11) and normal chromosome 11 ( Fig. 4B) , indicating that the breakpoint at 11q23 on the der(11) was telomeric to the MLL gene.
Discussion
On the basis of G-banding and SKY analyses, we defined an unbalanced translocation der(11)t(11;12)(q23;q13) in two cases of MDS with a complex karyotype. The breakpoints at 11q23 were telomeric to the MLL gene in both cases. Furthermore, in case 1, the NUP98 gene at 11p15 was not rearranged and located on the der(11)t(1;11)(q11;p15)t(1;11)t(11;12).
As shown in Table 1 , only three cases of hematological malignancies with t(11;12)(q23;q13) have been described in the literature to date [9] [10] [11] [12] .
All cases had complex karyotypes. Only the reported CLL case (Table 1) showed a balanced translocation and the t(11;12)(q23;q13) was not found in the stem line, suggesting that this aberration might have different role from others [10] . Common clinical features in these cases could not be found because only limited information was available, but the present two cases had some similar findings. That is, they were older and diagnosed as RAEB-t according to the high percentage of blasts in the peripheral blood.
Cytoplasmic hypogranulation of neutrophils was evident as a dysplastic change. Immunophenotypic analyses showed that the blasts were positive for monocytic marker CD4 and megakaryocytic marker CD41a as well as CD13, CD33, CD34 and HLA-DR. There is also another reported case with the der(11)t(11;12)(q23;q13) diagnosed as MDS, RAEB-t [12] . As a result, a total of three cases demonstrated the same phenotype, indicating that der(11)t(11;12)(q23;q13) is a recurrent cytogenetic abnormality in MDS, RAEB-t. Der(11)t(11;12)(q23;q13) may be involved in the pathogenesis of advanced-stage MDS, although it remains to be elucidated whether der(11)t(11;12)(q23;q13) is a primary genetic event or an additional change during disease progression of MDS. Furthermore, there is a possibility that the der(11)t(11;12)(q23;q13) may be a non-random, secondary, disease progression-related anomaly in a broad range of hematological malignan-cies because the der(11) has been observed in CLL and ALL as well as RAEB-t.
We examined MLL involvement at the 11q23 in the der(11)t(11;12)(q23;q13) and no rearrangement was found in the two cases;
it is unknown whether MLL was rearranged in other 3 reported cases. The majority of balanced 11q23 translocations result in the rearrangement of the MLL gene, but it has been shown that there is heterogeneity in the breakpoint in some of 11q23 rearrangements [13] . Namely, a number of 11q23 rearrangements clearly involved regions other than the MLL gene. For instance, breakpoints at 11q23 were telomeric to the MLL gene in ALL with t(11;14)(q23;q11) and malignant lymphoma with t(11;14)(q23;q32) [6, 13] . because of an immature phenotype and poor prognosis [17] . As observed in the present cases, the 12q13 translocation is often associated with concomitant dysmyelopoietic changes and occurs as a complex karyotype with other aberrations accompanying the translocation [17] [18] [19] . Chromosome region 12q13 is also known to contain several genes involved in tumorigenesis such as CHOP, CDK4, MDM2 and GLI [20, 21] . Recently, the HOXC13 gene was identified at 12q13 in AML with t(11;12)(p15;q13) that results in the formation of a novel NUP98/HOXC13 fusion [22] . It is possible that these genes at 12q13 might be involved in the der(11)t(11;12)(q23;q13).
It has been reported that many unbalanced translocations show duplication of a translocation participant. That is, a morphologically normal copy of one of the two chromosomes is acquired and this acquisition may compensate for one of the translocated segments [5] . However, the der(11)t(11;12)(q23;q13) is not followed by the gain of a normal chromosome 12 and consequently results in 12p monosomy. Deletions of 12p, such as del(12)(p11) and del(12)(p11p13), are recurrent cytogenetic abnormalities often observed in MDS or AML [23] . Loss of 12p in the der(11)t(11;12)(q23;q13) also may play a possible pathogenetic role by inducing functional loss of tumor suppressor genes [1] [2] [3] .
In the case 1, the der(11)t(11;12)(q23;q13) was accompanied by an additional translocation t(1;11)(q11;p15) and led to the formation of the der(11)t(1;11)(q11;p15)t(11;12)(q23;q13). The der(11)t(1;11)(q11;p15) has been reported as an additional cytogenetic abnormality in Philadelphia chromosome-positive ALL [24] . In addition, +der(11)t(1;11)(q11;p15) was described in multiple myeloma with a complex karyotype [25] . The NUP98 gene maps to 11p15 and was initially shown to be involved in t(7;11)(p15;p15) in AML [14] . The NUP98 gene is now known to be fused to more that 10 partner genes in various hematological malignancies [26] .
Hence, we examined the correlation with NUP98, but NUP98 was not involved in the der(11)t(1;11)(q11;p15) and the breakpoint at 11p15 was telomeric to the NUP98 gene.
The other common aberrations found in the 2 cases were deletions of 5q and 7q. G-banding analysis showed -5, -7, and several marker chromosomes as a part of complex karyotypes, and SKY clarified the origin of the marker chromosomes. Consequently, aberrations of chromosomes 5 and 7
were shown to be the results of unbalanced translocations or partial deletions, but not total losses of chromosomes 5 and 7 in both cases. The results of FISH with CSF1R and 7q31 probes were compatible with these findings.
Our results confirmed that the use of SKY combined with conventional G-banding analysis has assisted in the identification of important chromosomal rearrangements [27] . Kakazu et al. also showed by SKY analysis that some chromosome losses identified by G-banding were not complete, but chromosome fragments had been translocated to a variety of partner chromosomes [28] . Deletions of 5q and 7q are most frequent cytogenetic abnormalities and play an important role in the development of MDS [1] [2] [3] .
Complex cytogenetic abnormalities predominate in advanced-stage MDS and are associated with poor prognoses. In the present cases, complex karyotypes were observed at the initial diagnoses and the pathway of clonal evolution could not be clarified. Hence, at present, it is difficult to evaluate accurately the clinical significance of der(11)t(11;12)(q23;q13). Further cytogenetic and molecular analyses for more cases are needed to elucidate the pathogenesis of der(11)t(11;12)(q23;q13) in MDS. 43,XX,-1,add(2)(q35),-3,-5,-7,der (11) 41,X,-Y,der(3)(3qter->3q21::3p25->3qter),der(5)t(5;10)(q11;?),der(7)del (7) (p?)del(7)(q?),der(7)t(7;20)(p13;?)t(7;18)(q11;q11),der(11)t(11;12)(q23; q13),-12,der(13)t(13;17)(q11;q11),-14,der(16)t(14;16)(q13;q12),-17,-18, -20. Bentz et al, 1995 [10] 48/M ALL 46,XY,add(6)(p23),add(8)(p12),t(8;14)(q24;q32),der(11)t(11;12)(q23;q13),add(13)(q32)/ 46,idem,add(4)(q33),der(12)t(4;12)(q21;q13),-add(13),+add (13) Harrison et al, 1998 [11] NA RAEB-t 45,XX,-5,t(6;12)(p21;q13),t(9;19)(p13;q13),der(11)t(11;12)(q23;q13),-12,-17,+2r Michels et al, 1989 [12] 69/F RAEB-t 42,XX,der(1)del(1)(p?)t(1;3)(q21;?),der(2)t(2;5)(q35;?),-3,del(5)(q?),der (7) 69/M RAEB-t 41,X,-Y,der(3)(3qter->3q21::3p25->3qter),der(5)t(5;10)(q11;?),der(7)del(7)(p?)del(7)(q?), der(7)t(7;20)(p13;?)t(7;18)(q11;q11),der(11)t(11;12)(q23;q13),-12,der(13)t(13;17)(q11;q11),-14, der(16)t(14;16)(q13;q12),-17,-18,-20.
Figure legends
Case 2
Abbreviations: M, male; F, female; NA, not available; CLL, chronic lymphoid leukemia; ALL, acute lymphoblastic leukemia; RAEB-t, refractory anemia with excess of blasts in transformation.
